Status:

RECRUITING

Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication

Lead Sponsor:

Dana-Farber Cancer Institute

Conditions:

Advanced Cancer

Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this study is to test the accuracy of Large Language Model-generated serious illness communication (SIC) summaries, the feasibility of delivering the SIC summaries, and to collect perspect...

Detailed Description

The study will enroll up to 70 Dana-Farber patients admitted to Brigham and Women's hospital who have an elevated mortality prediction at admission. The research study procedures include randomization...

Eligibility Criteria

Inclusion

  • Participant
  • Dana-Farber Cancer Institute participants
  • Admission to an inpatient solid tumor medical oncology service at BWH (including beds that are considered to be DFCI beds within BWH)
  • Age ≥ 18 years
  • Mortality prediction ≥ 40%
  • Admitted on a Sunday after 4pm, Monday or Tuesday before 4pm. These time restrictions are necessary for the workflow of this pragmatic pilot trial, as an individual will need to send out the intervention emails and interview patients approximately 48-72 hours after admission, both of which need to occur during the work week.
  • Participant

Exclusion

  • Patients with elective inpatient admissions (typically for chemotherapy or other treatments)
  • Clinician Inclusion Criteria:
  • The clinician fills one of the following roles for the enrolled patient:
  • inpatient attending on the medical oncology team
  • outpatient Dana-Farber medical oncologist

Key Trial Info

Start Date :

September 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT07147023

Start Date

September 15 2025

End Date

October 31 2026

Last Update

November 28 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

2

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115